Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

NCT01693614

Conditions: Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

University of Nebraska Medical Center Univ Nebraska Omaha, Nebraska, United States

Memorial Sloan Kettering Dept of Onc. New York, United States

Medical University of South Carolina -Hollings Cancer Center Medical Univ of South Carolina Charleston, South Carolina, United States

View all 20 locations

View Trial Details

Completed

Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.

NCT01848132

Conditions: Diffuse, Large B-Cell, Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragon, Spain

Hospital Son Llàtzer Palma, Balearic Islands, Spain

Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain

Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain

View all 21 locations

View Trial Details

Completed

Refractory Diffuse Large B-cell Lymphoma

NCT03664336

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Centre Hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

NCT00453206

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +67 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer

NCT00134017

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Belinostat and Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Aggressive B-Cell NHL

NCT01686165

Conditions: Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

NCT00416312

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell Lymphoma

NCT00169143

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Hôpital Henri Mondor Créteil, France

Service d'Hématologie Clinique - CHU Le Bocage Dijon, France

Hôpital Saint Louis Paris, France

Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite, France

View Trial Details

Completed

Lenalidomide and R-CHOP in B-cell Lymphoma

NCT00901615

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: CHU de Dijon Dijon, France

CHRU Lille Lille, France

CHU Lyon Sud Pierre-Bénite, France

Centre Henri Becquerel Rouen, France

View Trial Details

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse trial results

Related conditions